Cytokinetics Overview
Cytokinetics Target Price
Analysts' 12-month price predictions for CYTK.
Get informed when a big investor buys or sells
+ FollowShare Price
$80.01
Average Target Price
$104.78
31% upside
31% upside9 analysts in the last 4 months
High: $140 | Low: $69
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-17 | RBC CapitalLeonid Timashev | $119 | 48.7% upside |  |
| 2026-05-11 | H.C. Wainwright | $140 | 75% upside | |
| 2026-05-06 | UBS | $119 | 48.7% upside | |
| 2026-05-06 | Stifel Nicolaus | $108 | 35% upside | |
| 2026-05-06 | Morgan Stanley | $103 | 28.7% upside | |
| 2026-05-05 | Truist FinancialSrikripa Devarakonda | $106 | 32.5% upside | |
| 2026-04-10 | Wells Fargo | $95 | 18.7% upside | |
| 2026-03-10 | Robert W. BairdRoanna Ruiz | $84 | 5% upside | |
| 2026-03-06 | UBSAshwani Verma | $69 |  13.8% downside | |
| 2026-02-20 | RBC Capital | $101 | 26.2% upside | |
| 2026-02-03 | Truist FinancialSrikripa Devarakonda | $92 | 15% upside | |
| 2026-01-09 | JefferiesAkash Tewari | $90 | 12.5% upside | |
| 2026-01-08 | Morgan StanleyMaxwell Skor | $90 | 12.5% upside | |
| 2025-12-22 | H.C. WainwrightJoseph Pantginis | $136 | 70% upside | |
| 2025-12-22 | Truist FinancialSrikripa Devarakonda | $84 | 5% upside | |
| 2025-12-22 | Morgan Stanley | $71 | 11.3% downside | |
| 2025-12-22 | Leerink PartnersRoanna Ruiz | $83 | 3.7% upside | |
| 2025-12-22 | RBC Capital | $95 | 18.7% upside | |
| 2025-12-22 | NeedhamSerge Belanger | $84 | 5% upside | |
| 2025-12-22 | Goldman Sachs | $99 | 23.7% upside | |
| 2025-12-22 | Barclays | $87 | 8.7% upside | |
| 2025-12-18 | Goldman Sachs | $95 | 18.7% upside | |
| 2025-12-01 | UBSAshwani Verma | $61 | 23.8% downside | |
| 2025-10-06 | BarclaysGena Wang | $82 | 2.5% upside | |
| 2025-09-03 | Evercore ISICory Kasimov | $80 | 0% upside | |
| 2025-09-03 | BarclaysGena Wang | $71 | 11.3% downside | |
| 2025-09-02 | Stifel NicolausJames Condulis | $96 | 20% upside | |
| 2025-04-24 | BarclaysGena Wang | $55 | 31.3% downside | |
| 2025-03-07 | Morgan Stanley | $67 | 16.3% downside | |
| 2024-10-17 | H.C. WainwrightJoseph Pantginis | $120 | 50% upside | |
| 2024-09-03 | Goldman SachsPaul Choi | $60 | 25% downside | |
| 2024-06-10 | Piper SandlerYasmeen Rahimi | $107 | 33.7% upside | |
| 2024-06-04 | B.Riley FinancialMayank Mamtani | $92 | 15% upside | |
| 2024-05-28 | JMP SecuritiesJason Butler | $78 | 2.5% downside | |
| 2024-05-23 | JefferiesAkash Tewari | $85 | 6.2% upside | |
| 2024-05-23 | H.C. WainwrightJoseph Pantginis | $90 | 12.5% upside | |
| 2024-05-23 | NeedhamSerge Belanger | $72 | 10% downside | |
| 2024-05-23 | BarclaysCarter Gould | $95 | 18.7% upside | |
| 2024-05-09 | JMP SecuritiesJason Butler | $106 | 32.5% upside | |
| 2024-05-09 | OppenheimerJustin Kim | $106 | 32.5% upside | |
| 2024-04-05 | Mizuho SecuritiesSalim Syed | $99 | 23.7% upside | |
| 2022-12-23 | Needham | $58 | 27.5% downside | |
| 2022-12-20 | Truist Financial | $60 | 25% downside | |
| 2022-08-23 | Raymond JamesDane Leone | $63 | 21.3% downside | |
| 2022-06-09 | Piper SandlerYasmeen Rahimi | $72 | 10% downside | |
| 2022-04-30 | H.C. WainwrightJoseph Pantginis | $75 | 6.3% downside | |
| 2021-12-20 | BarclaysCarter Gould | $52 | 35% downside | |
| 2021-11-18 | Raymond JamesDane Leone | $54 | 32.5% downside | |
| 2021-10-08 | Morgan StanleyJeffrey Hung | $45 | 43.8% downside | |